Immuron CEO, Steven Lydeamore to present at Bioshares
July 24 2023 - 6:00AM
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and
globally integrated biopharmaceutical company is pleased to advise
our Chief Executive Officer, Steven Lydeamore will be presenting at
the 17th Bioshares Biotech Summit in Hobart, Australia on July
24th.
A copy of the presentation slide deck
is available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
This release has been
authorised by the directors of Immuron Limited.
COMPANY CONTACT:
Steven LydeamoreChief Executive OfficerPh: +61
(0)3 9824 5254info@immuron.com
About ImmuronImmuron Limited
(ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical
company focused on developing and commercialising orally delivered
targeted polyclonal antibodies for the treatment of infectious
diseases.
For more information visit:
http://www.immuron.com
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Apr 2024 to May 2024
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From May 2023 to May 2024